Benchmark Investment Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,275
| Closed | -$277K | – | 90 |
|
|
2024
Q4 | $277K | Hold |
2,275
| – | – | 0.18% | 76 |
|
|
2024
Q3 | $284K | Hold |
2,275
| – | – | 0.2% | 73 |
|
|
2024
Q2 | $359K | Sell |
2,275
-105
| -4% | -$16.6K | 0.26% | 67 |
|
|
2024
Q1 | $308K | Sell |
2,380
-285
| -11% | -$36.9K | 0.24% | 76 |
|
|
2023
Q4 | $257K | Sell |
2,665
-640
| -19% | -$61.7K | 0.24% | 77 |
|
|
2023
Q3 | $401K | Sell |
3,305
-330
| -9% | -$40K | 0.4% | 61 |
|
|
2023
Q2 | $416K | Sell |
3,635
-5
| -0.1% | -$573 | 0.38% | 63 |
|
|
2023
Q1 | $502K | Sell |
3,640
-123
| -3% | -$17K | 0.52% | 54 |
|
|
2022
Q4 | $488K | Sell |
3,763
-120
| -3% | -$15.6K | 0.52% | 56 |
|
|
2022
Q3 | $429K | Buy |
3,883
+110
| +3% | +$12.2K | 0.46% | 60 |
|
|
2022
Q2 | $283K | Sell |
3,773
-150
| -4% | -$11.3K | 0.3% | 84 |
|
|
2022
Q1 | $306K | Sell |
3,923
-70
| -2% | -$5.46K | 0.23% | 106 |
|
|
2021
Q4 | $360K | Buy |
+3,993
| New | +$360K | 0.3% | 80 |
|